Pharmacology of nociceptin and its receptor: A novel therapeutic target

British Journal of Pharmacology

Volumn 129, Issue 7, 2000, Pages 1261-1283

  Calo', Girolamo ^a   Guerrini, Remo ^a   Rizzi, Anna ^a   Salvadori, Severo ^a   Regoli, Domenico ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Agonists; Antagonists; Nociceptin receptor; Nociceptin orphanin FQ; Receptor characterization and classification; Recombinant and native receptors

Indexed keywords

ADENYLATE CYCLASE; BETA ENDORPHIN; BINALTORPHIMINE; CALCIUM CHANNEL; CALCIUM ION; DECANOIC ACID DERIVATIVE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DYNORPHIN A; DYNORPHIN[1-8]; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; LEUCINE ENKEPHALIN; METENKEPHALIN; MORPHINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NALTRINDOLE; NOCICEPTIN; NOCICEPTIN RECEPTOR; OPIATE AGONIST; OPIATE ANTAGONIST; POTASSIUM CHANNEL; POTASSIUM ION; RECEPTOR SUBTYPE;

ANXIETY; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR FUNCTION; CENTRAL NERVOUS SYSTEM; DRUG MECHANISM; DRUG RECEPTOR BINDING; FOOD INTAKE; GASTROINTESTINAL MOTILITY; KIDNEY FUNCTION; LOCOMOTION; MEMORY; NERVE CELL; NEUROTRANSMITTER RELEASE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW;

EID: 0034101011     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703219     Document Type: Review

References (242)

1. Adam, G., Cesura, A., Galley, G., Jenck, F., Monsma, F., Rover, S. & Wichmann, J. (1998). New 8-substitute-1,3,8-triazaspiro[4.5]decan-4-on derivatives - useful for the treatment of diseases related to the Orphanin FQ receptor e.g. psychiatric, neurological and physiological disorders. Switzerland, EP-856514-A1.
2. Allen, C.N., Jiang, Z.G., Teshima, K., Darland, T., Ikeda, M., Nelson, C.S., Quigley, D.I., Yoshioka, T., Allen, R.G., Rea, M.A. & Grandy, D.K. (1999). Orphanin-FQ/nociceptin (OFQ/ N) modulates the activity of suprachiasmatic nucleus neurons. J. Neurosci., 19, 2152-2160.
3. Angeletti, S., Panocka, I., Ciccocioppo, R., Gini, L. & Massi, M. (1999). Effect of nociceptin on morphine-induced conditioned place preference in rats. Regulatory peptides, 80, 122.
4. Anton, B., Fein, J., To, T., Li, X., Silberstein, L. & Evans, C.J. (1996). Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J. Comp. Neurol., 368, 229-251.
5. Armstead, W.M. (1999). Nociceptin/orphanin FQ dilates pial arteries by K(ATP) and k(ca) channel activation. Brain Res., 835, 315-323.
6. Arndt, M.L., Wu, D., Soong, Y. & Szeto, H.H. (1999). Nociceptin/ orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep. Peptides, 20, 465-470.
7. Bauer, U., Nakazi, M., Kathmann, M., Gothert, M. & Schlicker, E. (1999). The stereoselective kappa-opioid receptor antagonist Mr 2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1) receptor. Naunyn Schmiedebergs Arch. Pharmacol., 359, 17-20.
8. Becker, J.A.J., Wallace, A., Garzon, A., Ingallinella, P., Bianchi, E., Cortese, R., Simonin, F., Kieffer, B.L. & Pessi, A. (1999). Ligands for k-opioid and ORL1 receptors identified from a conformationally constrained peptide combinatorial libray. J. Biolol. Chem., 274, 27513-27522.
9. Bertorelli, R., Citterio, F., Tupper, J. & Ongini, E. (1999b). Further analysis of nociceptin and derivatives following intratecal administration in mice. Regul. Peptides, 80, 122.
10. Bertorelli, R., Corradini, L., Rafiq, K., Tupper, J., Calo', G. & Ongini, E. (1999a). Nociceptin and the putative ORL-1 ligand [Phe1psi(CH2-NH)Gly2)]nociceptin(1-13)NH2 exert anti-opiod effects in the Freund's adiuvant-induced arthritis rat model of chronic pain. Br. J. Pharmacol., 128, 1252-1258.
11. Berzetei-Gurske, I.P., Schwartz, R.W. & Toll, L. (1996). Determination of activity for nociceptin in the mouse vas deferens. Eur. J. Pharmacol., 302, R1-R2.
12. Bigoni, R., Calo', G., Mitri, S. & Regoli, D. (1999b). Naloxone benzoylhydrazone acts as a non selective nociceptin receptor antagonist. Fund. Clin. Pharmacol., 13, 214s.
13. Bigoni, R., Giuliani, S., Calo', G., Rizzi, A., Guerrini, R., Salvadori, S., Regoli, D. & Maggi, C.A. (1999a). Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. Naunyn Schmiedebergs Arch. Pharmacol., 359, 160-167.
14. Bradford, H.F. (1995). Glutamate, GABA and epilepsy. Prog. Neurobiol., 47, 477-511.
15. Bregola, G., Candeletti, S., Romualdi, P. & Simonato, M. (1999). Limbic seizures increase pronociceptin mRNA levels in the thalamic reticular nucleus. Neuroreport, 10, 541-546.
16. Bucher, B. (1998). ORL1 receptor-mediated inhibition by nociceptin of noradrenaline release from perivascular sympathetic nerve endings of the rat tail artery. Naunyn Schmiedebergs Arch. Pharmacol., 358, 682-685.
17. Bunzow, J.R., Saez, C., Mortrud, M., Bouvier, C., Williams, J.T., Low, M. & Grandy, D.K. (1994). Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett., 347, 284-288.
18. 2 is an agonist of the nociceptin (ORL1) receptor. Eur. J. Pharmacol., 349, R5-R6.
19. Calo', G., Bigoni, R., Rizzi, A., Marzola, G., Guerrini, R., Salvadori, S., Regoli, D. & Bianchi, C. (1999). Characterization of nociceptin receptors modulating locomotor activity in mice. Fund. Clin. Pharmacol., 13-S1, S27.6.
20. Calo', G., Guerrini, R., Bigoni, R., Rizzi, A., Bianchi, C., Regoli, D. & Salvadori, S. (1998a). Structure-Activity Study of the Nociceptin(1-13)-NH2 N-Terminal Tetrapeptide and Discovery of a Nociceptin Receptor Antagonist. J. Med. Chem., 41, 3360-3366.
21. Calo', G., Guerrini, R., Bigoni, R., Rizzi, A., Marzola, G., Okawa, H., Bianchi, C., Lambert, D.G., Salvadori, S. & Regoli, D. (2000). Characterization of [Nphe1]NC(1-13)NH2, a new selective nociceptin receptor antagonist. Br. J. Pharmacol., 129, in press.
22. Calo', G., Rizzi, A., Bodin, M., Neugebauer, W., Salvadori, S., Guerrini, R., Bianchi, C. & Regoli, D. (1997). Pharmacological characterization of nociceptin receptor: an in vitro study. Can. J. Physiol. Pharmacol., 75, 713-718.
23. Calo', G., Rizzi, A., Bogoni, G., Neugebauer, W., Salvadori, S., Guerrini, R., Bianchi, C. & Regoli, D. (1996). The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur. J. Pharmacol., 311, R3-R5.
24. Calo', G., Rizzi, A., Marzola, G., Guerrini, R., Salvadori, S., Beani, L., Regoli, D. & Bianchi, C. (1998b). Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br. J. Pharmacol., 125, 373-378.
25. Candeletti, S., Guerrini, R., Calo', G. & Ferri, S. (1998). Effects of the nociceptin receptor antagonist Phe1psi(CH2NH)-Gly2NC(1-13)NH2 on nociception in rats. In 29th International Narcotic Research Conference. pp. A170. Garmisch-Partenkirchen, Germany, 20-25 July, 1998.
26. Carpenter, K.J. & Dickenson, A.H. (1998). Evidence that [Phe1 psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord. Br. J. Pharmacol., 125, 949-951.
27. Champion, H.C. & Kadowitz, P.J. (1997). Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat. Life Sci., 60, PL 241-245.
28. Champion, H.C., Pierce, R.L. & Kadowitz, P.J. (1998). Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat. Regul. Pept., 78, 69-74.
29. Champion, H.C., Wang, R., Hellstrom, W.J. & Kadowitz, P.J. (1997). Nociceptin, a novel endogenous ligand for the ORL1 receptor, has potent erectile activity in the cat. Am. J. Physiol., 273, E214-E219.
30. Chavkin, C., James, I.F. & Goldstein, A. (1982). Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science, 215, 413-415.
31. Chen, Y., Fan, Y., Liu, J., Mestek, A., Tian, M., Kozak, C.A. & Yu, L. (1994). Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett., 347, 279-283.
32. Chen, Y., Mestek, A., Liu, J., Hurley, J.A. & Yu, L. (1993). Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol., 44, 8-12.
33. Chiou, L.C. (1999). [Phe1psi(Ch2-NH)Gly2]nociceptin(1-13)NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray. Br. J. Pharmacol., 128, 103-107.
34. Chu, X., Xu, N., Li, P., Mao, L. & Wang, J.Q. (1999a). Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla. Brain Res., 829, 134-142.
35. Chu, X., Xu, N., Li, P. & Wang, J.Q. (1999b). The nociceptin receptor-mediated inhibition of the rat rostral ventrolateral medulla neurons in vitro. Eur. J. Pharmacol., 364, 49-53.
36. Ciccocioppo, R., Panocka, I., Polidori, C., Regoli, D. & Massi, M. (1999). Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology, 141, 220-224.
37. Civelli, O., Nothacker, H.P. & Reinscheid, R. (1998). Reverse physiology: discovery of the novel neuropeptide, orphanin FQ/ nociceptin. Crit. Rev. Neurobiol., 12, 163-176.
38. Clarke, S., Chen, Z., Hsu, M.S., Pintar, J.E., Hill, R.G. & Kitchen, I. (1999). Quantitative autoradiography of ORL1, mu, delta, and kappa opioid receptors in the brains of ORL1 or nociceptin (OFQ) knockout mice. In International Narcotics Research Conference. pp. Sun 74. Saratoga Springs, NY, July 10-15, 1999.
39. Connor, M., Vaughan, C.W., Chieng, B. & Christie, M.J. (1996). Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br. J. Pharmacol., 119, 1614-1618.
40. Corbett, A.D., Menzies, J.R.W., Davies, M.R.P. & Paterson, S.J. (1998). The pharmacological actions of nociceptin in the isolated colon of rat, mouse, and man. Naunyn Schmiedebergs Arch. Pharmacol., 358 (Suppl 1), P40.47.
41. Corbett, A.D., Paterson, S.J., McKnight, A.T., Magnan, J. & Kosterlitz, H.W. (1982). Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor. Nature, 299, 79-81.
42. Czapla, M.A., Champion, H.C. & Kadowitz, P.J. (1997). Decreases in systemic arterial and hindquarters perfusion pressure in response to nociceptin are not inhibited by naloxone in the rat. Peptides, 18, 1197-1200.
43. Darland, T., Heinricher, M.M. & Grandy, D.K. (1998). Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci., 21, 215-221.
44. Devine, D.P., Reinscheid, R.K., Monsma, F.J., Jr., Civelli, O. & Akil, H. (1996a). The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res., 727, 225-229.
45. Devine, D.P., Taylor, L., Reinscheid, R.K., Monsma, F.J., Jr., Civelli, O. & Akil, H. (1996b). Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem. Res., 21, 1387-1396.
46. Dhawan, B.N., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P.B., Portoghese, P.S. & Hamon, M. (1996). International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev., 48, 567-592.
47. Dhawan, B.N., Raghubir, R. & Hamon, M. (1998). Opioid receptors. In The IUPHAR compendium of receptor characterization and classification. ed. Girdlestone, D. pp. 218-226. London: IUPHAR Media Ltd.
48. Doi, N., Dutia, M.B. & Russell, J.A. (1998). Inhibition of rat oxytocin and vasopressin supraoptic nucleus neurons by nociceptin in vitro. Neuroscience, 84, 913-921.
49. Dooley, C.T. & Houghten, R.A. (1996). Orphanin FQ: receptor binding and analog structure activity relationships in rat brain. Life Sci., 59, 23-29.
50. Dooley, C.T., Spaeth, C.G., Berzetei-Gurske, I.P., Craymer, K., Adapa, I.D., Brandt, S.R., Houghten, R.A. & Toll, L. (1997). Binding and In vitro activities of peptides with high affinity for the Nociceptin/Orphanin FQ receptor, ORL1. J. Pharmacol. Exp. Ther., 283, 735-741.
51. Emmerson, P.J. & Miller, R.J. (1999). Pre- and post-synaptic actions of opioid and orphan opioid agonists in the rat arcuate nucleus and ventromedial hypothalamus in vitro. J. Physiol., 517, 431-445.
52. Erb, K., Liebel, J.T., Tegeder, I., Zeilhofer, H.U., Brune, K. & Geisslinger, G. (1997). Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. Neuroreport, 8, 1967-1970.
53. Evans, C.J., Keith, D.E., Jr., Morrison, H., Magendzo, K. & Edwards, R.H. (1992). Cloning of a delta opioid receptor by functional expression. Science, 258, 1952-1955.
54. Faber, E.S., Chambers, J.P., Evans, R.H. & Henderson, G. (1996). Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br. J. Pharmacol., 119, 189-190.
55. Fischer, A., Forssmann, W.G. & Undem, B.J. (1998). Nociceptin-induced inhibition of tachykinergic neurotransmission in guinea pig bronchus. J. Pharmacol. Exp. Ther., 285, 902-907.
56. Florin, S., Suaudeau, C., Meunier, J.C. & Costentin, J. (1996). Nociceptin stimulates locomotion and exploratory behaviour in mice. Eur. J. Pharmacol., 317, 9-13.
57. Florin, S., Suaudeau, C., Meunier, J.C. & Costentin, J. (1997). Orphan neuropeptide NocII, a putative pronociceptin maturation product, stimulates locomotion in mice. Neuroreport, 8, 705-707.
58. Fukuda, K., Kato, S., Mori, K., Nishi, M., Takeshima, H., Iwabe, N., Miyata, T., Houtani, T. & Sugimoto, T. (1994). cDNA cloning and regional distribution of a novel memeber of the opioid receptor family. FEBS Lett., 343, 42-46.
59. Girlestone, D. (1998). The IUPHAR compendium of receptor characterization and classification. London: IUPHAR Media, London, UK.
60. Giuliani, S., Lecci, A., Tramontana, M. & Maggi, C.A. (1998). The inhibitory effect of nociceptin on the micturition reflex in anaesthetized rats. Br. J. Pharmacol., 124, 156-672.
61. Giuliani, S., Lecci, A., Tramontana, M. & Maggi, C.A. (1999). Nociceptin protects capsaicin-sensitive afferent fibers in the rat urinary bladder from desensitization. Naunyn Schmiedeberg's Arch. Pharmacol., 360, 202-208.
62. Giuliani, S. & Maggi, C.A. (1996). Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br. J. Pharmacol., 118, 1567-1569.
63. Giuliani, S. & Maggi, C.A. (1997). Prejunctional modulation by nociceptin of nerve-mediated inotropic responses in guinea-pig left atrium. Eur. J. Pharmacol., 332, 231-236.
64. Giuliani, S., Tramontana, M., Lecci, A. & Maggi, C.A. (1997). Effect of nociceptin on heart rate and blood pressure in anaesthetized rats. Eur. J. Pharmacol., 333, 177-179.
65. Grandy, D.K., Bonci, A., Fiorillo, C.D., Darland, T., Riedl, M., Bunzow, J.R., Elde, R., Kalivas, P.W. & Williams, J.T. (1999). Modulation of the mesolimbic dopamine reward pathway by nociceptin-orphanin FQ. In International Narcotics Research Conference, 30th Meeting. Saratoga Springs, NY.
66. Gressens, P., Calo', G. & Evrard, P. (1999). Nociceptin potentiates neonatal white matter excitotoxicity. Regulatory peptides, 80, 123.
67. Griebel, G., Perrault, G. & Sanger, D.J. (1999). Orphanin FQ, a novel neuropeptide with anti-stress-like activity. Brain Res., 836, 221-224.
68. Grisel, J.E., Farrier, D.E., Wilson, S.G. & Mogil, J.S. (1998). [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo. Eur. J. Pharmacol., 357, R1-R3.
69. Grisel, J.E., Mogil, J.S., Belknap, J.K. & Grandy, D.K. (1996). Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuroreport, 7, 2125-2129.
70. Guerrini, R., Calo', G., Bigoni, R., Rizzi, A., Varani, K., Toth, G., Gessi, S., Borea, P.A., Salvadori, S. & Regoli, D. (1999). Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor. Regul. Peptides, 80, 124.
71. Guerrini, R., Calo', G., Rizzi, A., Bianchi, C., Lazarus, L.H., Salvadori, S., Temussi, P.A. & Regoli, D. (1997). Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J. Med. Chem., 40, 1789-1793.
72. Guerrini, R., Calo', G., Rizzi, A., Bigoni, R., Bianchi, C., Salvadori, S. & Regoli, D. (1998). A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol., 123, 163-165.
73. Gulland, J.M. & Robinson, R. (1923). The morphine group. Part I. A discussion of the constitutional problem. J. Chem. Soc., 980-998.
74. Gumusel, B., Hao. Q., Hyman, A., Chang, J.K., Kapusta, D.R. & Lippton, H. (1997). Nociceptin: an endogenous agonist for central opioid like1 (ORL1) receptors possesses systemic vasorelaxant properties. Life Sci., 60, PL141-PL145.
75. Gutierrez, R., Leff, P. & Anton, B. (1998). Inhibition of kindling development by nociceptin/orphanin FQ. In Society for Neurosciences. 536.18.
76. Hamon, M. (1998). The new approach to opioid receptors. NS Arch. Pharmacol., 358 (suppl 2), SA 5.3.
77. Handa, B.K., Land, A.C., Lord, J.A., Morgan, B.A., Rance, M.J. & Smith, C.F. (1981). Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors. Eur. J. Pharmacol., 70, 531-540.
78. Hao, J.X., Wiesenfeld-Hallin, Z. & Xu, X.J. (1997). Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat. Neurosci. Lett., 223, 49-52.
79. Hao, J.X., Xu, I.S., Wiesenfeld-Hallin, Z. & Xu, X.J. (1998). Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation. Pain, 76, 385-393.
80. Hara, N., Minami, T., Okuda-Ashitaka, E., Sugimoto, T., Sakai, M., Onaka, M., Mori, H., Imanishi, T., Shingu, K. & Ito, S. (1997). Characterization of nociceptin hyperalgesia and allodynia in conscious mice. Br. J. Pharmacol., 121, 401-408.
81. Hashimoto, Y., Calo', G., Guerrini, R., Smith, G. & Lambert, D.G. (2000) Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese ovary cells stably expressing the recombinant human nociceptin receptor. Neurosci. Lett., 278, 109-112.
82. Heinricher, M.M., McGaraughty, S. & Grandy, D.K. (1997). Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J. Neurophysiol., 78, 3351-3358.
83. Helyes, Z., Nemeth, J., Pinter, E. & Szolcsanyi, J. (1997). Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br. J. Pharmacol., 121, 613-615.
84. Henderson, G. & McKnight, A.T. (1997). The orphan opioid receptor and its endogenous ligand nociceptin/orphanin FQ. Trends Pharmacol. Sci., 18, 293-300.
85. Hiramatsu, M. & Inoue, K. (1999). Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. Eur. J. Pharmacol., 367, 151-155.
86. Houtani, T., Nishi, M., Takeshima, H., Nukada, T. & Sugimoto, T. (1996). Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem. Biophys. Res. Commun., 219, 714-719.
87. Hughes, J., Kosterlitz, H.W. & Leslie, F.M. (1975a). Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antagonist potencies of narcotic analgesics. Br. J. Pharmacol., 53, 371-381.
88. Hughes, J., Smith, T.W., Kosterlitz, H.W., Fothergill, L.A., Morgan, B.A. & Morris, H.R. (1975b). Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature, 258, 577-580.
89. Ikeda, K., Watanabe, M., Ichikawa, T., Kobayashi, T., Yano, R. & Kumanishi, T. (1998). Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J. Comp. Neurol., 399, 139-151.
90. Inoue, M., Kobayashi, M., Kozaki, S., Zimmer, A. & Ueda, H. (1998). Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice. Proc. Natl. Acad. Sci. U.S.A., 95, 10949-10953.
91. Inoue, M., Shimohira, I., Yoshida, A., Zimmer, A., Takeshima, H., Sakurada, T. & Ueda, H. (1999). Dose-Related Opposite Modulation by Nociceptin/Orphanin FQ of Substance P Nociception in the Nociceptors and Spinal Cord. J. Pharmacol. Exp. Ther., 291, 308-313.
92. Jenck, F., Moreau, J.L., Martin, J.R., Kilpatrick, G.J., Reinscheid, R.K., Monsma, F.J., Jr., Nothacker, H.P. & Civelli, O. (1997). Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U.S.A., 94, 14854-14858.
93. Jenkinson, D.H., Barnard, E.A., Hoyer, D., Humphrey, P.P.A., Leff, P. & Shankley, N.P. (1995). International Union of Pharmacology Commitee on receptor nomenclature and drug classification XI Recommendations on terms and symbols in quantitative pharmacology. Pharmacol. Rev., 47, 255-266.
94. Kamei, J., Ohsawa, M., Kashiwazaki, T. & Nagase, H. (1999). Antinociceptive effects of the ORL1 receptor agonist nociceptin/ orphanin FQ in diabetic mice. Eur. J. Pharmacol., 370, 109-116.
95. Kapusta, D.R., Chang, J.K. & Kenigs, V.A. (1999). Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats. J. Pharmacol. Exp. Ther., 289, 173-180.
96. Kapusta, D.R., Sezen, S.F., Chang, J.K., Lippton, H. & Kenigs, V.A. (1997). Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci., 60, PL15-PL21.
97. Kavaliers, M. & Perrot-Sinal, T.S. (1996). Pronociceptive effects of the neuropeptide, nociceptin, in the land snail, Cepaea nemoralis. Peptides, 17, 763-768.
98. Kieffer, B.L., Befort, K., Gaveriaux-Ruff, C. & Hirth, C.G. (1992). The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A., 89, 12048-12052.
99. King, M., Chang, A. & Pasternak, G.W. (1998). Functional blockade of opioid analgesia by orphanin FQ/nociceptin. Biochem. Pharmacol., 55, 1537-1540.
100. King, M.A., Rossi, G.C., Chang, A.H., Williams, L. & Pasternak, G.W. (1997). Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci. Lett., 223, 113-116.
101. Knoflach, F., Reinscheid, R.K., Civelli, O. & Kemp, J.A. (1996). Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J. Neurosci., 16, 6657-6664.
102. Kobayashi, T., Ikeda, K., Togashi, S., Itoh, N. & Kumanishi, T. (1997). Effects of sigma ligands on the nociception/orphanin FQ receptor co-expressed with the G-protein-activated K + channel in Xenopus oocytes. Br. J, Pharmacol., 120, 986-987.
103. Konya, H., Masuda, H., Itoh, K., Nagai, K., Kakishita, E. & Matsuoka, A. (1998). Modification of dopamine release by nociceptin in conscious rat striatum. Brain Res., 788, 341-344.
104. Koster, A., Montkowski, A., Schulz, S., Stube, E.M., Knaudt, K., Jenck, F., Moreau, J.L., Nothacker, H.P., Civelli, O. & Reinscheid, R.K. (1999). Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. U.S.A., 96, 10444-10449.
105. Lachowicz, J.E., Shen, Y., Monsma, F.J. & Sibley, D.R. (1995). Molecular cloning of a novel G protein coupled receptor related to the opiate receptor family. Journal of Neurochemistry, 64, 34-40.
106. Lahti, R.A., Mickelson, M.M., McCall, J.M. & Von Voigt-Lande, P.F (1985). [3H]U-69593 a highly selective ligand for the opioid kappa receptor. Eur. J. Pharmacol., 109, 281-284.
107. Lecci, A., Giuliani, S., Tramontana, M., Criscuoli, M. & Maggi, C.A. Multiple sites of action in the inhibitory effect of nociceptin on the mictrurition reflex. J. Urol., in press.
108. Lee, K., Nicholson, J.R. & McKnight, A.T. (1997). Nociceptin hyperpolarises neurones in the rat ventromedial hypothalamus. Neurosci. Lett., 239, 37-40.
109. Leventhal, L., Mathis, J.P., Rossi, G.C., Pasternak, G.W. & Bodnar, R.J. (1998). Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia. Eur. J. Pharmacol., 349, R1-R3.
110. Li, C.H. & Chung, D. (1976). Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. Proc. Natl. Acad. Sci. U.S.A., 73, 1145-1148.
111. Liebel, J.T., Swandulla, D. & Zeilhofer, H.U. (1997). Modulation of excitatory synaptic transmission by nociceptin in superficial dorsal horn neurones of the neonatal rat spinal cord. Br. J. Pharmacol., 121, 425-432.
112. Luke, M.C., Hahn, E.F., Price, M. & Pasternak, G.W. (1988). Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexone. Life Sci., 43, 1249-1256.
113. Lutfy, K., Sharza, S.A. & Maidment, N.T. (1999). Tolerance develops to the inhibitory effect of orphanin FQ on morphine-induced antinociception in the rat. Neuroreport, 10, 103-106.
114. Madeddu, P., Salis, M.B., Milia, A.F., Emanueli, C., Guerrini, R., Regoli, D. & Calo', G. (1999). Cardiovascular effects of nociceptin in unanesthetized mice. Hypertension, 33, 914-919.
115. Maggi, C.A., Theodorsson, E., Santicioli, P. & Giuliani, S. (1992). Tachykinins and calcitonin gene-related peptide as cotransmitters in local motor responses produced by sensory nerve activation in the guinea-pig isolated renal pelvis. Neuroscience, 46, 549-559.
116. Mamiya, T., Noda, Y., Nishi, M., Takeshima, H. & Nabeshima, T. (1999). Nociceptin system plays a role in the memory retention: involvement of naloxone benzoylhydrazone binding sites. Neuroreport, 10, 1171-1175.
117. Manabe, T., Noda, Y., Mamiya, T., Katagiri, H., Houtani, T., Nishi, M., Noda, T., Takahashi, T., Sugimoto, T., Nabeshima, T. & Takeshima, H. (1998). Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature, 394, 577-581.
118. Marti, M., Sbrenna, S., Calo', G., Bianchi, C., Beani, L. & Morari, M. (1999). Facilitation of glutamate release via ORL1 receptors in the sbstantia nigra. A microdialysis study in the awake rat. Regulatory Peptides, 80, 124.
119. Meis, S. & Pape, H.C. (1998). Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to Nociceptin/Orphanin FQ. J. Neurosci., 18, 8133-8144.
120. Meunier, J.C. (1997). Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol., 340, 1-15.
121. Meunier, J.C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.L., Guillemot, J.C., Ferrara, P., Monserrat, B., Mazarguil, H., Vassart, G., Parmentier, M. & Costentin, J. (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature, 377, 532-535.
122. Minami, T., Okuda-Ashitaka, E., Nishiuchi, Y., Kimura, T., Tachibana, S., Mori, H. & Ito, S. (1998). Anti-nociceptive responses produced by human putative counterpart of nocistatin. Br. J. Pharmacol., 124, 1016-1018.
123. Minami, T., Okuda-Ashitaka, E., Nishizawa, M., Mori, H. & Ito, S. (1997). Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2. Br. J. Pharmacol., 122, 605-610.
124. Mogil, J.S., Grisel, J.E., Reinscheid, R.K., Civelli, O., Belknap, J.K. & Grandy, D.K. (1996a). Orphanin FQ is a functional anti-opioid peptide. Neuroscience, 75, 333-337.
125. Mogil, J.S., Grisel, J.E., Zhangs, G., Belknap, J.K. & Grandy, D.K. (1996b). Functional antagonism of mu-, delta-and kappa-opioid antinociception by orphanin FQ. Neurosci. Lett., 214, 131-134.
126. Mogil, J.S., Nessim, L.A. & Wilson, S.G. (1999). Strain-dependent effects of supraspinal orphanin FQ/nociceptin on thermal nociceptive sensitivity in mice. Neurosci. Lett., 261, 147-150.
127. Mollereau, C., Parmentier, M., Mailleux, P., Butour, J.L., Moisand, C., Chalon, P., Caput, D., Vassart, G. & Meunier, J.C. (1994). ORL1, a novel member of the opioid receptor family Cloning, functional expression and localization. FEBS Lett., 341, 33-38.
128. Mollereau, C., Simons, M.J., Soularue, P., Liners, F., Vassart, G., Meunier, J.C. & Parmentier, M. (1996). Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc. Natl. Acad. Sci. U.S.A., 93, 8666-8670.
129. Monteillet-Agius, G., Fein, J., Anton, B. & Evans, C.J. (1998). ORL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing. J. Comp. Neurol., 399, 373-383.
130. Montiel, J.L., Cornille, F., Roques, B.P. & Noble, F. (1997). Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24. 15. J. Neurochem., 68, 354-361.
131. Morgan, M.M., Grisel, J.E., Robbins, C.S. & Grandy, D.K. (1997). Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. Neuroreport, 8, 3431-3434.
132. Mosberg, H.I., Hurst, R., Hruby, V.J., Gee, K., Yamamura, H.I., Galligan, J.J. & Burks, T.F. (1983). Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc. Natl. Acad. Sci. U.S.A., 80, 5871-5874.
133. Murphy, N.P., Lee, Y. & Maidment, N.T. (1999a). Orphanin FQ/ nociceptin blocks acquisition of morphine place preference. Brain Res., 832, 168-170.
134. Murphy, N.P., Ly, H.T. & Maidment, N.T. (1996). Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience, 75, 1-4.
135. Murphy, N.P. & Maidment, N.T. (1999). Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J. Neurochem., 73, 179-186.
136. Murphy, N.P., Tam, A.M., Lam, H.A. & Maidment, N.T. (1999b). Orphanin FQ/nociceptin modulation of dopamine release from midbrain primary cultures. In International Narcotics Research Conference, 30th meeting. Saratoga Springs, NY, July 10-15, 1999.
137. Nakagawa, T., Kaneko, M., Inamura, S. & Satoh, M. (1999). Intracerebroventricular administration of nocistatin reduces inflammatory hyperalgesia in rats. Neurosci. Lett., 265, 64-66.
138. Narayanan, S. & Maidment, N.T. (1999). Orphanin FQ and behavioral sensitization to cocaine. Pharmacol. Biochem. Behav., 63, 271-277.
139. Neal, C.R., Jr., Mansour, A., Reinscheid, R., Nothacker, H.P., Civelli, O. & Watson, S.J., Jr. (1999). Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol., 406, 503-547.
140. Neal, M.J., Cunningham, J.R., Paterson, S.J. & McKnight, A.T. (1997). Inhibition by nociceptin of the light-evoked release of ACh from retinal cholinergic neurones. Br. J. Pharmacol., 120, 1399-1400.
141. Nemeth, J., Helyes, Z., Oroszi, G., Than, M., Pinter, E. & Szolcsanyi, J. (1998). Inhibition of nociceptin on sensory neuropeptide release and mast cell-mediated plasma extravasation in rats. Eur. J. Pharmacol., 347, 101-104.
142. Nicholson, J.R., Mason, S.L., Lee, K. & McKnight, A.T. (1998b). The effect of the agonist Ac-RYYRWKNH2 and the antagonist [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 at the ORL1 receptor of central and peripheral sites. In 29th International Narcotics Research Conference. A129, Garmisch-Partenkirchen (Germany), 20-25 July 1998.
143. Nicholson, J.R., Paterson, S.J. & McKnight, A.T. (1996). Characterization of the response in the rat vas deferens to the ORL-1 agonist nociceptin. Br. J. Pharmacol., 119 Proceeding Suppl, 36P.
144. Nicholson, J.R., Paterson, S.J., Menzies, J.R., Corbett, A.D. & McKnight, A.T. (1998a). Pharmacological studies on the 'orphan' opioid receptor in central and peripheral sites. Can. J. Physiol. Pharmacol., 76, 304-313.
145. Nicol, B., Lambert, D.G., Rowbotham, D.J., Okuda-Ashitaka, E., Ito, S., Smart, D. & McKnight, A.T. (1998a). Nocistatin reverses nociceptin inhibition of glutamate release from rat brain slices. Eur. J. Pharmacol., 356, R1-R3.
146. Nicol, B., Lambert, D.G., Rowbotham, D.J., Smart, D. & McKnight, A.T. (1996). Nociceptin induced inhibition of K + evoked glutamate release from rat cerebrocortical slices. Br. J. Pharmacol., 119, 1081-1083.
147. Nicol, B., Rowbotham, D.J., Smart, D., McKnight, A.T. & Lambert, D.G. (1998b). Nociceptin inhibits glutamate release from rat cerebellar slices. Br. J. Pharmacol., 123, 217P.
148. Nishi, M., Houtani, T., Noda, Y., Mamiya, T., Sato, K., Doi, T., Kuno, J., Takeshima, H., Nukada, T., Nabeshima, T., Yamashita, T., Noda, T. & Sugimoto, T. (1997). Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor. EMBO J., 16, 1858-1864.
149. Nishi, M., Takeshima, H., Mori, M., Nakagawara, K. & Takeuchi, T. (1994). Structure and chromosomal mapping of genes for the mouse κ-opioid receptor and an opioid receptor homologue (MORC). Biochem. Biophys. Res. Commun., 205, 1353-1357.
150. Noble, F. & Roques, B.P. (1997). Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice. FEBS Lett., 401, 227-229.
151. Noda, Y., Mamiya, T., Nabeshima, T., Nishi, M., Higashioka, M. & Takeshima, H. (1998). Loss of antinociception induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice. J. Biol. Chem., 273, 18047-18051.
152. Nothacker, H.P., Reinscheid, R.K., Mansour, A., Henningsen, R.A., Ardati, A., Monsma, F.J., Watson, S.J. & Civelli, O. (1996). Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. U.S.A., 93, 8677-8682.
153. Okawa, H., Nicol, B., Bigoni, R., Hirst, R.A., Calo', G., Guerrini, R., Rowbotham, D.J., Smart, D., McKnight, A.T. & Lambert, D.G. (1999). Comparison of the effects of Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rut brain, rat vas deferens and CHO cells expressing recombinant human nociceptin recetors. Br. J. Pharmacol., 127, 123-130.
154. Okuda-Ashitaka, E., Minami, T., Tachibana, S., Yoshihara, Y., Nishiuchi, Y., Kimura, T. & Ito, S. (1998). Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature, 392, 286-289.
155. Okuda-Ashitaka, E., Tachibana, S., Houtani, T., Minami, T., Masu, Y., Nishi, M., Takeshima, H., Sugimoto, T. & Ito, S. (1996). Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: its involvement in allodynic response to innocuous stimulus. Brain Res. Mol. Brain Res., 43, 96-104.
156. 2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-I15 neuroblastoma cells. Neuroreport, 10, 1127-1131.
157. Olofson, R.A., Schnur, R.C., Bunes, L. & Pepe, J.P. (1977). Selective N-dealkylation of tertiary amines with vinyl chloroformate: an improved synthesis of naloxone. Tetrahedron Letters, 18, 1567-1570.
158. Osinski, M.A., Bass, P. & Gaumnitz, E.A. (1999b). Peripheral and central actions of orphanin FQ (nociceptin) on murine colon. Am. J. Physiol., 276, G125-G131.
159. Osinski, M.A., Pampusch, M.S., Murtaugh, M.P. & Brown, D.R. (1999a). Cloning, expression and functional role of a nociceptin/orphanin FQ receptor in the porcine gastrointestinal tract. Eur. J. Pharmacol., 365, 281-289.
160. Ozaki, S., Kawamoto, H., Ito, Y., Hayashi, K., Iwasawa, Y. & Hirano, K. (1998). New 2-oxoimidazole derivatives are nociceptin receptor binding inhibitors useful e.g. as analgesics and for amelioreting brain function. Japan, WO9854168-A1.
161. Pan, Y.X., Xu, J. & Pasternak, G.W. (1996). Cloning and expression of a cDNA encoding a mouse brain orphanin FQ nociceptin precursor. Biochem. J., 315, 11-13.
162. Pan, Y.X., Xu, J., Wan, B.L., Zuckerman, A. & Pasternak, G.W. (1998). Identification and differential regional expression of KOR-3/ORL-1 gene splice variants in mouse brain. FEBS Lett., 435, 65-68.
163. Patel, H.J., Giembycz, M.A., Spicuzza, L., Barnes, P.J. & Belvisi, M.G. (1997). Naloxone-insensitive inhibition of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by the novel opioid, nociceptin. Br. J. Pharmacol., 120, 735-736.
164. Paton, W.D.M. (1957). The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea pig ileum. Br. J. Pharmacol., 12, 119-127.
165. Paul, D., Levison, J.A., Howard, D.H., Pick, C.G., Hahn, E.F. & Pasternak, G.W. (1990). Naloxone benzoylhydrazone (NalB-zoH) analgesia. J. Pharmacol. Exp. Ther., 255, 769-774.
166. Pelton, J.T., Gulya, K., Hruby, V.J., Duckles, S.P. & Yamamura, H.I. (1985). Conformationally restricted analogs of somatostatin with high mu-opiate receptor specificity. Proc. Natl. Acad. Sci. U.S.A., 82, 236-239.
167. Peluso, J., Laforge, K.S., Matthes, H.W., Kreek, M.J., Kieffer, B.L. & Gaveriaux-Ruff, C. (1998). Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells. J. Neuroimmunol., 81, 184-192.
168. Pheng, L.H., Calo', G. & Regoli, D. (1999). Ileon de lapin: une preparation sensible a Ia nociceptine. In 41 annual meeting of the Club de recherche clinique du Quebec. Montreal, Quebec, CA, Oct 1999.
169. Pieretti, S. & Di Giannuario, A. (1999). Orphanin FQ effects on morphine-induced dopamine release in the accumbens of rats. Regulatory Peptides, 80, 126.
170. Polidori, C., Calo', G., Ciccocioppo, R., Guerrini, R., Regoli, D. & Massi, M. (2000). Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology, in press.
171. Polidori, C., Calo', G., Decaro, G., Regoli, D., Pompei, P. & Massi, M. (1999). Sensitivity of brain sites to the orexigenic effect of nociceptin or af its analog [Phe1psi(CH2-NH)Gly2]NC(1-13)NH2. Regul. Peptides, 80, 126.
172. Pomonis, J.D., Billington, C.J. & Levine, A.S. (1996). Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport, 8, 369-371.
173. Portoghese, A.S., Lipkowski, A.W. & Takemori, A.E. (1987). Bimorphinans as highly selective, potent kappa opioid receptor antagonists. J. Med. Chem., 30, 238-239.
174. Portoghese, P.S. (1989). Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists. Trends Pharmacol. Sci., 10, 230-235.
175. Portoghese, P.S., Sultana, M. & Takemori, A.E. (1988). Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur. J. Pharmacol., 146, 185-186.
176. Reinscheid, R.K., Ardati, A., Monsma, F.J., Jr. & Civelli, O. (1996). Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J. Biol. Chem., 271, 14163-14168.
177. Reinscheid, R.K., Knaudt, K., Koester, A., Montkowski, A. & Civelli, O. (1999). OFQ/N and the endogenous opioids act synergistically in protecting from excessive sensation of fear and pain. In International Narcotics Research Conference, 30th meeting. Saratoga Springs, NY, July 10-15, 1999.
178. Reinscheid, R.K., Nothacker, H.P., Bourson, A., Ardati, A., Henningsen, R.A., Bunzow, J.R., Grandy, D.K., Langen, H., Monsma, F.J., Jr. & Civelli, O. (1995). Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science, 270, 792-794.
179. 2 antagonizes nociceptin effects in the mouse colon. Eur. J. Pharmacol., 285, R3-R5.
180. Rizzi, A., Calo', G., Trevisani, M., Tognetto, M., Fabbri, L., Mapp, C., Guerrini, R., Salvadori, S., Regoli, D. & Geppetti, P. (1999a). Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus. Life Sci., 64, L157-L163.
181. Rossi, G.C., Mathis, J.P. & Pasternak, G.W. (1998). Analgesic activity of orphanin FQ2, murine prepro-orphanin FQ141-157 in mice. Neuroreport, 9, 1165-1168.
182. Rowland, N.E., Morien, A. & Li, B.H. (1996). The physiology and brain mechanisms of feeding. Nutrition, 12, 626-639.
183. Sakurada, T., Katsuyama, S., Sakurada, S., Inoue, M., Tanno, K., Kisara, K., Sakurada, C., Ueda, H. & Sasaki, J. (1999). Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors. Br. J. Pharmacol., 127, 1712-1718.
184. Salvadori, S., Guerrini, R., Calo', G. & Regoli, D. (1999). Structure activity studies on nociceptin/orphanin FQ: from full agonist, to partial agonist, to pure antagonist. Il Famaco, 54, 810-825.
185. Sandin, J., Georgieva, J., Schott, P.A., Ogren, S.O. & Terenius, L. (1997). Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur. J. Neurosci., 9, 194-197.
186. Sandin, J., Georgieva, J., Silberring, J. & Terenius, L. (1999). In vivo metabolism of nociceptin/orphanin FQ in rat hippocampus. Neuroreport, 10, 71-76.
187. Sbrenna, S., Marti, M., Morari, M., Calo', G., Guerrini, R., Beani, L. & Bianchi, C. (1999). 5-HT, Glu and GABA efflux from rat cerebrocortical synaptosomes: modulation by opioid receptor like 1 receptor. Regul. Peptides, 80, 127.
188. Sbrenna, S., Marti, M., Morari, M., Calo', G., Guerrini, R., Beani, L. & Bianchi, C. Modulation of 5-HT efflux from rat cortical synaptosomes by opioids and nociceptin. Br. J. Pharmacol., in press.
189. Schild, H.O. (1973). Receptor classification with special reference to beta adrenergic receptors. In Drug receptors, pp. 29-36. Baltimore: University Park Press.
190. Schiller, P.W., Nguyen, T.M., Weltrowska, G., Wilkes, B.C., Marsden, B.J., Lemieux, C. & Chung, N.N. (1992). Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists. Proc. Natl. Acad. Sci. U.S.A., 89, 11871-11875.
191. Schlicker, E., Werthwein, S., Kathmann, M. & Bauer, U. (1998). Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 358, 418-422.
192. Schulz, S., Schreff, M., Nuss, D., Gramsch, C. & Hollt, V. (1996). Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not colocalization in pain-modulatory brain regions. Neuroreport, 7, 3021-3025.
193. Schwyzer, R. (1986). Molecular mechanism of opioid receptor selection. Biochemistry, 25, 6335-6342.
194. Seki, T., Awamura, S., Kimura, C., Ide, S., Sakano, K., Minami, M., Nagase, H. & Satoh, M. (1999). Pharmacological properties of TRK-820 on cloned mu-, delta-and kappa-opioid receptors and nociceptin receptor. Eur. J. Pharmacol., 376, 159-167.
195. Shah, S., Page, C.P. & Spina, D. (1998). Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br. J. Pharmacol., 125, 510-516.
196. Shimohigashi, Y., Hatano, R., Fujita, T., Nakashima, R., Nose, T., Sujaku, T., Saigo, A., Shinjo, K. & Nagahisa, A. (1996). Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide. J. Biol. Chem., 271, 23642-23645.
197. Sim, L.J. & Childers, S.R. (1997). Anatomical distribution of mu, delta, and kappa opioid-and nociceptin/orphanin FQstimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain. J. Comp. Neurol., 386, 562-572.
198. Siniscalchi, A., Rodi, D., Beani, L. & Bianchi, C. (1999). Inhibitory effect of nociceptin on [3H]5-HT release from the rat cerebral cortex slices. Br. J. Pharmacol., 128, 119-123.
199. Slugg, R.M., Ok, R.N., Grandy, D.K. & Kelly, M.J. (1999). Activation of an Inwardly Rectifying K + Conductance by Orphanin-FQ/Nociceptin in Vasopressin-Containing Neurons. Neuroendocrinology, 69, 385-396.
200. Stanfa, L.C., Chapman, V., Kerr, N. & Dickenson, A.M. (1996). Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo. Br. J. Pharmacol., 118, 1875-1877.
201. Stratford, T.R., Holahan, M.R. & Kelley, A.E. (1997). Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. Neuroreport, 8, 423-426.
202. Sulaiman, M.R., Niklasson, M., Tham, R. & Dutia, M.B. (1999). Modulation of vestibular function by nociceptin/orphanin FQ: an in vivo and in vitro study. Brain Res., 828, 74-82.
203. Taniguchi, H., Yomota, E., Nogi, K., Onoda, Y. & Ikezawa, K. (1998). The effect of nociceptin, an endogenous ligand for the ORL1 receptor, on rat colonic contraction and transit. Eur. J. Pharmacol., 353, 265-271.
204. Taylor, F. & Dickenson, A. (1998). Nociceptin/orphanin FQ. A new opioid, a new analgesic? Neuroreport, 9, R65-R70.
205. Tian, J.H., Xu, W., Fang, Y., Mogil, J.S., Grisel, J.E., Grandy, D.K. & Han, J.S. (1997b). Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br. J. Pharmacol., 120, 676-680.
206. Tian, J.H., Xu, W., Zhang, W., Fang, Y., Grisel, J.E., Mogil, J.S., Grandy, D.K. & Han, J.S. (1997a). Involvement of endogenous orphanin FQ in electroacupuncture-induced analgesia. Neuroreport, 8, 497-500.
207. Tian, J.H., Zhang, W., Fang, Y., Xu, W., Grandy, D.K. & Han, J.S. (1998). Endogenous orphanin FQ: evidence for a role in the modulation of electroacupuncture analgesia and the development of tolerance to analgesia produced by morphine and electroacupuncture. Br. J. Pharmacol., 124, 21-26.
208. Toll, L., Burnside, J. & Berzetei-Gurske, I. (1998). Agonist activity of ORL1 antagonists is dependent upon receptor number. In INRC 1998. pp. A89. Garmisch-Partenkirchen, Germany, 2025 July, 1998.
209. Ueda, H., Yamaguchi, T., Tokuyama, S., Inoue, M., Nishi, M. & Takeshima, H. (1997). Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci. Lett., 237, 136-138.
210. Varani, K., Calo', G., Rizzi, A., Merighi, S., Toth, G., Guerrini, R., Salvadori, S., Borea, P.A. & Regoli, D. (1998). Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships. Br. J. Pharmacol., 125, 1485-1490.
211. Varani, K., Rizzi, A., Calo', G., Bigoni, R., Toth., G., Guerrini, R., Gessi, S., Salvadori, S., Borea, P.A. & Regoli, D. (1999). Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies. Naunyn Schmiedebergs Arch. Pharmacol., 360, 270-277.
212. Vaughan, C.W. & Christie, M.J. (1996). Increase by the ORL1 receptor (opioid receptor-like 1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br. J. Pharmacol., 117, 1609-1611.
213. Vaughan, C.W., Ingram, S.L. & Christie, M.J. (1997). Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci., 17, 996-1003.
214. Vlaskovska, M., Kasakov, L., Suder, P., Silberring, J. & Terenius, L. (1999). Biotransformation of nociceptin/orphanin FQ by enzyme activity from morphine-naive and morphine-treated cell cultures. Brain Res., 818, 212-220.
215. Walker, J.R., Spina, M., Terenius, L. & Koob, G.F. (1998). Nociceptin fails to affect heroin self-administration in the rat. Neuroreport, 9, 2243-2247.
216. Wang, J.B., Johnson, P.S., Imai, Y., Persico, A.M., Ozenberger, B.A., Eppler, C.M. & Uhl, G.R. (1994). cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett., 348, 75-79.
217. Wang, X.M., Zhang, K.M. & Mokha, S.S. (1996). Nociceptin (orphanin FQ), an endogenous ligand for the QRL1 (opioid receptor-like 1) receptor; modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli. J. Neurophysiol., 76, 3568-3572.
218. Wang, Y.Q., Zhu, C.B., Cao, X.D. & Wu, G.C. (1999a). Supraspinal hyperalgesia and spinal analgesia by [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)-NH2 in rat. Eur. J. Pharmacol., 376, R1-R3.
219. Wang, Y.Q., Zhu, C.B., Wu, G.C., Cao, X.D., Wang, Y. & Cui, D.F. (1999b). Effects of orphanin FQ on endomorphin-1 induced analgesia. Brain Res., 835, 241-246.
220. Werthwein, S., Bauer, U., Nakazi, M., Kathmann, M. & Schlicker, E. (1999). Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro. Br. J. Pharmacol., 127, 300-308.
221. Wichmann, J., Adam, G., Rover, S., Cesura, A.M., Dautzenberg, F.M. & Jenck, E. (1999). 8-Acenaphthen-1-YL-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one derivatives as orphanin fq receptor agonists. Bioorg. Med. Chem. Lett., 9, 2343-2348.
222. Wick, M.J., Minnerath, S.R., Lin, X., Elde, R., Law, P.Y. & Loh, H.H. (1994). Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. Brain Res. Mol. Brain Res., 27, 37-44.
223. Wick, M.J., Minnerath, S.R., Roy, S., Ramakrishnan, S. & Loh, H.H. (1995). Expression of alternate forms of brain opioid 'orphan' receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines. Brain Res. Mol. Brain Res., 32, 342-347.
224. Wise, R.A. (1989). Opiate reward: sites and substrates. Neurosci. Biobehav. Rev., 13, 129-133.
225. Wnendt, S., Kruger, T., Janocha, E., Hildebrandt, D. & Englberger, W. (1999). Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay. Mol. Pharmacol., 56, 334-338.
226. Xu, I.S., Wiesenfeld-Hallin, Z. & Xu, X.J. (1998). [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci. Lett., 249, 127-130.
227. Xu, X.J., Hao, J.X. & Wiesenfeld-Hallin, Z. (1996). Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport, 7, 2092-2094.
228. Yamamoto, T., Nozaki-Taguchi, N. & Kimura, S. (1997a). Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like 1 receptor agonist, in the rat formalin test. Neuroscience, 81, 249-254.
229. Yamamoto, T., Nozaki-Taguchi, N. & Kimura, S. (1997b). Effects of intrathecally administered nociceptin, an opioid receptor-like 1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by carageenan injection into the rat paw. Brain Res., 754, 329-332.
230. Yamamoto, T. & Sakashita, Y. (1999). Effect of nocistatin and its interaction with nociceptin/orphanin FQ on the rat formalin test. Neurosci. Lett., 262, 179-182.
231. Yasuda, K., Raynor, K., Kong, H., Breder, C.D., Takeda, J., Reisine, T. & Bell, G.I. (1993). Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. Natl. Acad. Sci. U.S.A., 90, 6736-6740.
232. Yazdani, A., Takahashi, T., Bagnol, D., Watson, S.J. & Owyang, C. (1999). Functional significance of a newly discovered neuropeptide, orphanin FQ. in rat gastrointestinal motility. Gastroenterology, 116, 108-117.
233. Yoshikawa, M., Takahashi, M. & Yunden, J. (1999). Analgesic and cognition-enhancing activity of retronociceptin methyl-ester, a nociceptin antagonist. In International Narcotic Research Conference. Saratoga Springs, NY, July 10-15, 1999. pp. Sun63.
234. Yu, J., Chait, B.T., Toll, L. & Kreek, M.J. (1996). Nociceptin in vitro biotransformation in human blood. Peptides, 17, 873-876.
235. Yu, T.P., Fein, J., Phan, T., Evans, C.J. & Xie, C.W. (1997). Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus, 7, 88-94.
236. Yu, T.P. & Xie, C.W. (1998). Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms. J. Neurophysiol., 80, 1277-1284.
237. Yuan, L., Han, Z., Chang, J.K. & Han, J.S. (1999). Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats. Brain Res., 826, 330-334.
238. Zadina, J.E., Hackler, L., Ge, L.J. & Kastin, A.J. (1997). A potent and selective endogenous agonist for the μ opiate receptor. Nature, 386, 499-502.
239. Zgodzinski, W., Rubaj, A., Gustaw, K., Sieklucka-Dziuba, M. & Kleinrok, Z. (1999). Anticonvulsant effects of orphanin FQ receptor ligands. In International Narcotics Research Conference. Saratoga Springs, NY, July 10-15, 1999.
240. Zhang, G., Murray, T.F. & Grandy, D.K. (1997). Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens. Brain Res., 772, 102-106.
241. Zhu, C.B., Cao, X.D., Xu, S.E. & Wu, G.C. (1997). Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci. Lett., 235, 37-40.
242. Zhu, C.B., Xu, S.F., Cao, X.D., Wu, G.C., Zhang, X.L., Li, M.Y., Cui, D.F. & Chi, C.W. (1996). Antagonistic action of orphanin FQ on acupuncture analgesia in rat brain. Acupunct. Electrother. Res., 21, 199-205.